Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-10 Sale |
2024-01-12 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
8,000 | $27.91 | $223,280 | 85,664 (Direct) |
View |
| 2023-11-16 Sale |
2023-11-20 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
2,500 | $28.01 | $70,025 | 117,089 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
9,093 | $28.5 | $259,151 | 33,231 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
1,110 | $28.13 | $31,224 | 5,681 (Direct) |
View |
| 2023-08-30 Sale |
2023-09-01 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
8,100 | $32 | $259,200 | 99,149 (Direct) |
View |
| 2023-08-25 Sale |
2023-08-29 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
5,135 | $31.59 | $162,215 | 85,249 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-16 5:00 pm |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank Sr VP, Quality, GMP Oper. & IT |
4,780 | $35.99 | $172,023 | 4,737 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-22 Option Award |
2024-02-26 5:01 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
13,621 | $0 | 97,678 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:01 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director |
13,621 | $0 | 13,621 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:01 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
13,621 | $0 | 46,852 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:01 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
357,000 | $0 | 2,276,455 (Direct) |
View |
| 2024-02-22 Tax Withholding |
2024-02-26 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
335 | $27.94 | 38,801 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
31,740 | $0 | 38,801 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
62,500 | $0 | 69,004 (Direct) |
View |
| 2024-02-22 Tax Withholding |
2024-02-26 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
246 | $27.94 | 87,668 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
750 | $0 | 87,668 (Direct) |
View |
| 2024-02-12 Other |
2024-02-22 5:28 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
16,500 | $0 | 1,952,455 (Direct) |
View |
| 2024-01-10 Exercise |
2024-01-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
8,000 | $9.24 | 85,664 (Direct) |
View |
| 2024-01-10 Exercise |
2024-01-12 5:00 pm |
N/A 2024-01-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
8,000 | $0 | 85,664 (Direct) |
View |
| 2023-12-22 Exercise |
2023-12-26 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan Sr. VP, Chief Medical Officer |
600 | $0 | 3,243 (Direct) |
View |
| 2023-12-22 Tax Withholding |
2023-12-26 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan Sr. VP, Chief Medical Officer |
204 | $27.66 | 3,243 (Direct) |
View |
| 2023-12-22 Exercise |
2023-12-26 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
25,000 | $0 | 1,919,455 (Direct) |
View |
| 2023-12-22 Tax Withholding |
2023-12-26 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
11,958 | $27.66 | 1,919,455 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
25,000 | $0 | 1,931,413 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer |
600 | $0 | 3,447 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
7,457 | $9.24 | 117,089 (Direct) |
View |
| 2023-11-16 Exercise |
2023-11-20 5:00 pm |
2015-01-21 2024-01-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director |
7,457 | $0 | 117,089 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
7,457 | $9.24 | 33,231 (Direct) |
View |
| 2023-11-15 Exercise |
2023-11-17 5:00 pm |
2015-01-21 2024-01-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director |
7,457 | $0 | 33,231 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
2,000 | $9.24 | 5,681 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 5:00 pm |
N/A 2024-01-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT |
2,000 | $0 | 5,681 (Direct) |
View |
| 2023-10-13 Exercise |
2023-10-13 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
4,000 | $0 | 5,089 (Direct) |
View |
| 2023-10-13 Tax Withholding |
2023-10-13 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
1,911 | $26.91 | 5,089 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-06 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
4,000 | $0 | 7,000 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-07 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
2,500 | $0 | 7,165 (Direct) |
View |
| 2023-09-07 Tax Withholding |
2023-09-07 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
1,182 | $32.1 | 7,165 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-07 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
35,000 | $0 | 1,906,413 (Direct) |
View |
| 2023-09-07 Tax Withholding |
2023-09-07 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
16,804 | $32.1 | 1,906,413 (Direct) |
View |
| 2023-08-30 Exercise |
2023-09-01 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
8,100 | $23.99 | 99,149 (Direct) |
View |
| 2023-08-30 Exercise |
2023-09-01 5:00 pm |
N/A 2030-02-21 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
8,100 | $0 | 99,149 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-25 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
35,000 | $0 | 1,923,217 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-25 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
2,500 | $0 | 8,347 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-21 5:10 pm |
N/A 2033-08-17 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director |
24,153 | $0 | 24,153 (Direct) |
View |
| 2023-05-11 Tax Withholding |
2023-05-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
709 | $36.47 | 2,650 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
1,500 | $0 | 2,650 (Direct) |
View |
| 2023-05-11 Tax Withholding |
2023-05-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
15,005 | $36.47 | 1,888,217 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
31,250 | $0 | 1,888,217 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
750 | $0 | 5,497 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-08 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
31,250 | $0 | 1,903,222 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-08 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
1,500 | $0 | 3,359 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-08 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
750 | $0 | 5,497 (Direct) |
View |
| 2023-02-22 Option Award(A) |
2023-04-12 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
500 | $0 | 2,648 (Direct) |
View |
| 2023-02-22 Tax Withholding(A) |
2023-04-12 5:01 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
193 | $38.57 | 2,648 (Direct) |
View |
| 2023-02-22 Option Award(A) |
2023-04-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank Sr VP, Quality, GMP Oper. & IT |
750 | $0 | 11,478 (Direct) |
View |
| 2023-02-22 Tax Withholding(A) |
2023-04-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank Sr VP, Quality, GMP Oper. & IT |
289 | $38.57 | 11,478 (Direct) |
View |
| 2023-02-22 Option Award(A) |
2023-04-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
750 | $0 | 92,284 (Direct) |
View |
| 2023-02-22 Tax Withholding(A) |
2023-04-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
289 | $38.57 | 92,284 (Direct) |
View |
| 2023-04-11 Option Award |
2023-04-12 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
1,500 | $0 | 4,747 (Direct) |
View |
| 2023-03-14 Exercise |
2023-04-10 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
1,500 | $0 | 2,052 (Direct) |
View |
| 2023-03-14 Tax Withholding |
2023-04-10 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO |
789 | $38.65 | 2,052 (Direct) |
View |
| 2023-03-14 Exercise |
2023-04-10 5:00 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO |
20,000 | $0 | 1,871,972 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:04 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO |
25,000 | $0 | 28,247 (Direct) |
View |